141 related articles for article (PubMed ID: 8943399)
1. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
2. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Kwok WW; Nepom GT; Raymond FC
J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
5. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior.
Chaves FA; Richards KA; Torelli A; Wedekind J; Sant AJ
Biochemistry; 2006 May; 45(20):6426-33. PubMed ID: 16700553
[TBL] [Abstract][Full Text] [Related]
6. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
7. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH on MHC class II-peptide interactions.
Sette A; Southwood S; O'Sullivan D; Gaeta FC; Sidney J; Grey HM
J Immunol; 1992 Feb; 148(3):844-51. PubMed ID: 1730877
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC.
Liang MN; Lee C; Xia Y; McConnell HM
Biochemistry; 1996 Nov; 35(47):14734-42. PubMed ID: 8942634
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Reizis B; Altmann DM; Cohen IR
Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
[TBL] [Abstract][Full Text] [Related]
11. Definition of a DQ3.1-specific binding motif.
Sidney J; Oseroff C; del Guercio MF; Southwood S; Krieger JI; Ishioka GY; Sakaguchi K; Appella E; Sette A
J Immunol; 1994 May; 152(9):4516-25. PubMed ID: 7512598
[TBL] [Abstract][Full Text] [Related]
12. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
13. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
[TBL] [Abstract][Full Text] [Related]
14. In vitro maximum binding of antigenic peptides to murine MHC class II molecules does not always take place at the acidic pH of the in vivo endosomal compartment.
Nag B; Passmore D; Deshpande SV; Clark BR
J Immunol; 1992 Jan; 148(2):369-72. PubMed ID: 1370312
[TBL] [Abstract][Full Text] [Related]
15. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQB1 codon 57 is critical for peptide binding and recognition.
Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM
J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268
[TBL] [Abstract][Full Text] [Related]
17. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
Yaneva R; Springer S; Zacharias M
Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
[TBL] [Abstract][Full Text] [Related]
18. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
19. Prediction of HLA-DQ3.2beta ligands: evidence of multiple registers in class II binding peptides.
Tong JC; Zhang GL; Tan TW; August JT; Brusic V; Ranganathan S
Bioinformatics; 2006 May; 22(10):1232-8. PubMed ID: 16510499
[TBL] [Abstract][Full Text] [Related]
20. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]